Abstract Medical thoracoscopy is an important technique for assessment of undiagnosed exudative pleural effusion. It is also important in the management of pleural disease, benign or malignant. Standard equipment available from several manufacturers enables the procedure to be performed through a single port of entry, frequently under conscious sedation. With good patient selection, thoracoscopy is a highly successful and safe procedure. Adequate training is mandatory and a period of mentoring is highly recommended. In this paper we discuss the use of thoracoscopy for some benign and malignant conditions and reveal that controversy remains over issues including the optimum mode and agent for pleurodesis. In addition, opinions differ on the precise role of thoracoscopy for pleural infection. In this paper we discuss key background information necessary for the safe provision of thoracoscopy. We then undertake a review of recent literature addressing important aspects of this procedure.
Introduction
Although Jacobaeus is credited with the development of thoracoscopy, the first literature report was that of Samuel Gordon who, in 1866, described exploration of the pleural cavity of an 11-year-old girl with empyema [1] . This first procedure was performed in 1865 by the Irish physician Francis Richard Cruise. However, it was Jacobaeus who made the procedure more operator-friendly by improving the endoscopic view by induction of a pneumothorax at the onset of the procedure [2] .
The term thoracoscopy encompasses a range of procedures, including those performed by the physician (medical thoracoscopy, pleuroscopy, or local anaesthetic thoracoscopy) and, more recently, the emergence of "video-assisted thoracoscopic surgery" (VATS) performed by surgeons. The procedure undertaken by pulmonologists is usually performed in the endoscopy suite under local anaesthesia and with intravenous conscious sedation and/or analgesia, whereas VATS requires general anaesthesia and double lumen tracheal intubation in the operating room. The range of indications and intervention performed differ between the two procedures. Medical thoracoscopy is frequently indicated for diagnostic purposes (pleural effusions) and for talc pleurodesis ("poudrage") to prevent recurrence of persistent pleural effusions or pneumothorax. Surgeons using VATS perform more advanced procedures, including pulmonary nodule resection and lobectomies.
Indications
Although the basic technique of thoracoscopy is standard worldwide, the range of indications varies depending on the resources, experience, and skills of the operator. The common indications reported in the literature are listed in Table 1 .
Equipment and training
A detailed description of thoracoscopy technique can be found in recent reviews, and is beyond the scope of this review article [3, 4] . Thoracoscopy should be performed in a suitable clinical environment with appropriate facilities to maintain "surgical equivalent" sterile technique. The standard operating equipment required for thoracoscopy includes a boutin needle, a trocar consisting of an obturator and a canula, a directviewing and angle-viewing optical telescope, an optical forceps, and a light source (Fig. 1) . In the event of complications, for example haemorrhage, an insulated trocar is necessary for a second port through which electrocautery can be performed. Additional necessary equipment is listed in Table 2 . Thoracic ultrasound (TUS) is preferable before induction of pneumothorax, because it identifies a safe site of entry, even in complex pleural spaces [5, 6] .
The optimum diameter of the thoracoscope (trocar and telescope) is 7 mm, as originally developed by Boutin in conjunction with the Wolff Corporation ( Knittlingen, Germany). Larger telescopes (diameter 10-12 mm) are available but have been developed with the surgeon in mind and in which the procedure will be performed under general anaesthesia and double lumen intubation. However, they are impractical for a procedure performed under local anaesthesia.
More recently, such techniques as minithoracoscopy and flexi-rigid thoracoscopy have been described in the literature. Minithoracoscopy, using a 2-5 mm trocar has promising diagnostic yields; it enables adequate visualization of the pleural space but takes longer to perform and may encounter difficulties with the management of adhesions [7] . Tassi et al. achieved a diagnostic yield of 93 % by use of a 3 mm thoracoscope [8] . In a paper comparing 2-mm, 3-mm, and standard thoracoscopes, the authors achieved diagnostic yields of 40 %, 100 %, and 100 % for the 2-mm, 3-mm, and 7-mm equipment, respectively [9] .
The semi-rigid and/or flexible thoracoscope has advantages and disadvantages compared with traditional rigid thoracoscopy. Although the rigid thoracoscope enables excellent vision, large biopsy samples using a single port of entry, ease of biopsy from harder lesions, and easy orientation inside the pleural cavity, the flexible equipment enables lateral vision or retrovisualization (which would require a separate obliqueview telescope when using rigid instruments), while maintaining high diagnostic yield [10, 11] . In addition, physicians who are skilled with the flexible bronchoscope may feel more comfortable with the semi-rigid thoracoscope.
It is mandatory that the operator is skilled in the technique of thoracoscopy and has an excellent command of pleural anatomy and the associated landmarks. The optimum way of learning often starts with a practical course incorporating a theoretical component (organized courses are available in Europe and the USA). The American College of Chest Physicians published their interventional pulmonary procedures guideline in 2003, these recommendations advise a minimum of 20 procedures in a supervised setting to ensure basic competence and at least 10 procedures per year to maintain competence [12] . However it is our opinion that a period of mentoring in a busy thoracoscopy service is preferable before commencing independent practice. In addition, all supporting staff should be well versed in the procedure and comfortable with all aspects of the equipment.
The vast majority of procedures, including talc poudrage, can be performed through a single port of entry if the initial trocar size is at least 5 mm in diameter. A second port of entry is occasionally indicated. This point of entry is located one Grasping forceps and a swab holder Sterile covers for the cables attaching the optics and camera to the lighting source Plastic sterile aspiration tubes, 4 and 6 mm in diameter Aspiration tubing and collection bottles of at least 2 litre capacity Cupulas for local anaesthetic (LA), warm saline-used to prevent fogging of the optics-and soap Chest drains ranging from size 20 to 32 fr A guide for the chest drain or a self contained chest tube set with an inner stylet intercostal space superior or inferior to the primary port of entry or in the setting of haemorrhage, located to enable electrocoagulation of the site of bleeding. Indications for a second port include situations where the movement of the trocar is sufficiently painful to prevent a full inspection of the area of interest. This complication can be minimized by choosing the position carefully at the outset with the aid of available radiographs, computed tomography (CT), and pre-procedure TUS. Occasionally, however, simple geographical problems between the entry point and the lesion or a narrow intercostal space prevents complete manoeuvrability of the trocar. Although application of local anaesthesia enables excellent management of the immediate area of entry, it has no effect on the ribs; this may result in pain if they are forcefully pushed up or down by the movement of the thoracoscope. Large adhesions may sometimes prevent full examination of the pleural cavity. If so, a second access point should be created. Finally, if electocautery is needed for haemostasis, the physician must be able to create a second port of entry quickly. This can be placed rapidly under direct vision. The chosen site is viewed through the primary port with the optic while the assistant depresses the preferred second entry site on the chest wall. The external compression can be easily visualized on the internal chest wall and a trocar can be placed rapidly.
Complications
Thoracoscopy is usually a safe procedure. Mortality is 0.35 % (95 % confidence interval 0.19-0.54 %), and likely to be less if diagnostic procedures alone are performed [3] . This compares favourably with mortality for transbronchial biopsy (0.22-0.6 %) [13, 14] and mediastinoscopy (0.17 %) [15] . Major complications (empyema, haemorrhage, port site tumour growth, bronchopleural fistula and/or persistent air leak, postoperative pneumothorax, and pneumonia) occur in 1.8 % (95 % CI 1.4-2.2 %) and minor complications (subcutaneous emphysema, minor haemorrhage, operative skin site infection, fever, and atrial fibrillation) in 7.3 % (95 % CI 6.3-8.4 %) [3] .
Update
The following sections cover recent important advances in the field of thoracoscopy.
Procedural
Use of thoracic ultrasound in thoracoscopy has been discussed in several papers. Medford et al. reported that after the introduction of pleural ultrasound, success of pleural access improved from 83.7 % to 100 % (p = 0.052) [16] . Furthermore, it facilitated identification of adhesions which were poorly detected on CT scans. Use of thoracic ultrasound to predict the presence of adhesions before thoracoscopy has been assessed in a surgical setting [17, 18] . Both studies demonstrated that ultrasound is effective when used by experienced operators. Medford, in a recent letter published in the journal Respiratory Medicine, emphasized the potential cost benefit of thoracic ultrasound before medical thoracoscopy in an NHS hospital setting [19] . In a cohort of 30 patients undergoing thoracoscopy without thoracic ultrasound, five patients required additional invasive investigation, with an associated significant additional cost. He argues that the cost of implementing thoracic ultrasound before routine medical thoracoscopy would be recovered within a year.
Sedation
There is limited or no information about the optimum method for sedation or analgesia during medical thoracoscopy [3] . Tschopp et al. discussed the use of propofol by nonanaesthetists in medical thoracoscopy [20] . This was a feasibility and safety study in which 53 patients were enrolled. The duration of the median procedure was 28 min, the median propofol dose required was 145 mg, and an additional median dose of 84 mcg fentanyl was administered. Haemodynamic complications were the most common reported adverse event (n = 39); including hypotension for 34 patients. However, the dosing algorithm required the use of haemodynamic monitoring and a bi-spectral index, which could make this less appealing to physicians working primarily in endoscopy units without anaesthetic backup.
Agnoletti et al. assessed the feasibility of multilevel thoracic paravertebral blocks (T3-T7) [21] . Defining primary and secondary outcomes, they reported good overall response with few complications. They used 0.2 mg kg −1 midazolam. For the 26 patients enrolled in the study, pain during the procedure and vasovagal syncope for two patients were reported. This is obviously an additional skill requiring supplementary staff to be present at the time of medical thoracoscopy, but is a potential alternative for patients deemed unsuitable for standard methods of sedation and/or analgesia.
Complications
Physiological response to medical thoracoscopy was assessed by Froudarakis et al. [22] . They measured mean inspiratory and expiratory pressures (MIP and MEP) and lung function pre-procedure and serially post-procedure. They identified an initial reduction in both inspiratory and expiratory pressures and lung function in the first 24 h after the procedure. A small drop in oxygen saturation was also noted. Recovery back to baseline was the norm after a few days. Despite the reporting of studies which have revealed the safety of talc as a pleurodesis agent, the debate continues [23] [24] [25] [26] . Lee discussed the merits of different techniques for management of malignant pleural effusions. Evidence supports talc as the most effective agent for pleurodesis with reported success of 81 to 100 %. This compares favourably to other agents, for example tetracycline (65-76 %) or bleomycin (61 %). A recent large multicentre study in Europe has confirmed the safety of graded talc for patients with pleural space malignancy. Talc poudrage via thoracoscopy is the preferred choice for pleurodesis with better outcomes than for talc slurry. In addition, poudrage was better tolerated by patients. Indwelling pleural catheters are a viable alternative, particularly for patients who fail chemical pleurodesis. However this technique may not be cost effective if overall life expectancy is greater than six weeks.
Light has reported good results with indwelling pleural catheters compared with chemical pleurodesis. However one of the studies compared the catheter to doxycycline, an inferior agent for pleurodesis compared with talc. In any case, it seems clear that the use of the indwelling pleural catheter results in shorter initial hospital stays and, hence, less cost. This cost saving may not continue if the patient has a prolonged survival because of the need for frequent drainage of fluid. Light also discusses the ongoing concerns about the safety of talc-especially the development of ARDS. However most studies used ungraded talc with smaller particles. Two European multicentre studies enrolling patients with malignant effusions and pneumothorax, respectively, utilized graded talc. These studies found no cases of ARDS. The superiority of poudrage over slurry is also questioned. However it is important to emphasize that thoracoscopy has additional advantages over chest drainage-visualisation of the pleural space, biopsies, removal of adhesions, etc. The debate is likely to continue.
Brims et al. reported outcomes for 58 patients for whom thoracoscopy had been performed over a twelve-month period [27] . Of note, the study geographical area has a high prevalence of mesothelioma because of the proportion of the population with known dockyard exposure. Hospital-acquired infections (pneumonia or empyema) proved to be the most problematic complication, occurring in six (10.5 %) patients. Infection affected length of stay and prolonged the duration of in-situ chest drainage. Although no deaths occurred in the immediate post-procedure period, four patients died within a month-three of whom had hospital-acquired infections. Mootha et al, reporting retrospective data between 2007 and 2008 in an Indian tertiary referral hospital with a differing range of pleural disease, reported similar incidence of empyema, which occurred in two of 35 cases (5.2 %) [28] . They reported few complications overall-a valuable contribution to the development of this diagnostic procedure in a country where asbestos exposure remains a long-term problem and will become important in the future for undiagnosed exudative pleural effusions [29] .
Malignant pleural disease
In the management algorithm in BTS guidelines, thoracoscopy remains an alternative to intercostal drain insertion and is indicated if there is no evidence of trapped lung, with a view to performing talc poudrage-probably the optimum method for pleurodesis [30, 31] . The suitability of thoracoscopy for trapped lung is unclear. However, it should be stated that thoracoscopy enables more than simple therapeutic management of the pleural space. It enables visualization of pleural and diaphragmatic surfaces and identification and possible ligation of adhesions which may affect optimum pleurodesis. Indwelling pleural catheters (IPC), placed at the time of the procedure, may be useful for patients who have probable trapped lung at the time of thoracoscopy [32, 33] . These studies suggest placement of an IPC may be preferable as a single procedure in this difficult to manage population with malignant pleural disease.
An interesting follow up study on patients with fibrinous pleuritis, revealed the incidence of false-negative biopsies was 18 % [34•]. Use of thoracoscopy for visual interpretation of the pleural space, CT findings, and female gender, were all risk factors for malignant disease. These findings were similar to those published by Davies et al., and have recently been the subject of detailed review [35, 36] .
Metintas et al. reported a randomized study comparing CT-guided Abraham needle biopsy and thoracoscopy biopsy for 124 patients with undiagnosed exudative pleural effusions [37] . Although thoracoscopy had higher sensitivity for malignant disease (87 % versus 94.1 %, respectively), the difference was not statistically significant. With the increase in pulmonologists utilising thoracic ultrasound and/or thoracoscopy and familiarity performing guided procedures, it is unlikely that CT-guided Abraham needle biopsy will become widely adopted.
Role in staging
Hubbard et al. reported a small case series in which thoracoscopy was used for assessment of patients with Pancoast tumours without clear radiographic evidence of chest wall invasion [38] . By use of thoracoscopy, invasion was identified in eight of twelve (75 %) patients, and reduced the time to initiation of definitive treatment (chemotherapy and/or radiotherapy; 22.3 days versus surgery 60 days). Although primarily surgical, Fleury et al. reported use of pre-operative thoracoscopy for patients with presumed advanced ovarian carcinoma. Thoracoscopic assessment of the pleural cavity upstaged 27 of 75 patients with stage IIIc ovarian cancer who were initially being considered for cytoreductive surgery before the results from the thoracoscopy [39] .
Complicated parapneumonic effusions and empyema
Although the most recent British Thoracic Society (BTS) guidelines on pleural infection did not envisage use of medical thoracoscopy [40] , the BTS local anaesthetic thoracoscopy guideline report acknowledged the procedure may be useful for division of septations and adhesions, thus creating a single pleural cavity and improving drainage [3] . Although the literature reports high success (91.7 %), these data are derived from case series which lack direct comparisons or a control group [41] [42] [43] . Use of medical thoracoscopy in the management of an infected pleural space continues to stimulate debate. Although some believe surgery to be the optimum management, no studies have rigorously addressed this question. As VATS replaces open thoracotomy [44] , natural progression to medical thoracoscopy is likely to be inevitable and, indeed, is already relatively common practice in some centres in Europe.
Good data are available on conservative treatment outcomes in the management of pleural-based infection, so difficulties remain in defining when surgery should be performed, and, by extension, when medical thoracoscopy should be included in overall management. It is likely that the timing of the procedure, the complexity of the pleural space, and the skill of the thoracoscopist will affect this. It seems that an interesting transition is occurring in pleural infection, in which management strategies could be moving to different ends of the range-with even more conservative management treatment strategies (involving antibiotics, small or no drains) or immediate pleural clearance under medical thoracoscopy or surgical VATS. No studies have definitively addressed these issues. However, Ravaglia et al. retrospectively reported on six years experience with 41 patients with multiloculated and organized empyema [45] . Overall success of 35 (85.4 %) was reported, but success dropped to 50 % for patients defined as having an "organized" empyema. A denominator and clear selection criteria for procedure would be preferable in such a study, but it does seem that in highly selected patients thoracoscopy is an acceptable management choice. Whether there is benefit over more conservative management remains unclear, but in specific situations it should be considered when all options are addressed and balanced. Tassi et al. discussed the use of thoracoscopy in the management of parapneumonic effusions and empyema, and argued that it may be cost-effective and may avoid progression to VATS [46] . Finally it must be borne in mind that thoracoscopy for pleural infection is defined as an advanced procedure by the authors, and should only be undertaken by very experienced pulmonologists.
Pneumothorax
In Europe use of thoracoscopy early in the management of primary spontaneous pneumothorax is common practice. This is supported by a single randomised study comparing talc poudrage versus intercostal drainage, with recurrence of 5.1 % and 34 %, respectively, at five years [47] . However the BTS guidelines recommend surgical referral on the basis that it is a definitive procedure with good results and a greater range of therapeutic options [48] . Comparative studies of use of medical thoracoscopy versus VATS thoracoscopy are required, and are the subject of current research [49••] .
Education
As new techniques become available in interventional thoracic medicine, training remains a pertinent issue. Holt et al. reported a study on the educational effectiveness of a thoracoscopy short course [50] . Pre-course and post-course examinations, assessing both cognitive and technical skills, resulted in significant improvements in this self-selecting group of pulmonologists who had no formal training in thoracoscopy. Meanwhile, integration of a thoracoscopy video-based educational tool for anatomy undergraduates proved more beneficial than small group lectures, with nearly 70 % of students perceiving benefit [51] . Clearly, a combined approach of visual and/or spatial stimulation and practical engagement coupled with core knowledge will ensure that participants benefit maximally from short courses. However, a period of mentoring will always be required before participants become independent in this procedure.
Conclusion
Medical thoracoscopy is a growing field in interventional pulmonology, with an increasing number of physicians performing the technique. With the increasing availability of this minimally invasive procedure it is imperative that good practice is maintained via ongoing audit. Key research questions must be addressed in multicentred studies, and new techniques should be evaluated to improve the safety and efficacy of the procedure and provide better clinical outcomes for patients with pleural disease-both benign and malignant.
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